Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable.
For more info please visit www.zelluna.com
Company Details
- Employees
- 30
- Founded
- 2016
- Address
- Manager Jobs
- Phone
- 47 22 84 00 80
- po****@****una.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- zelluna.com
Zelluna Questions
Zelluna's helpline number is 47 22 84 00 80
Zelluna's website is zelluna.com
Zelluna's LinkedIn profile is https://no.linkedin.com/company/zelluna
Zelluna has
30 employees.
View email and phone details for 30
employees at Zelluna.
Zelluna's industry is
Biotechnology Research
Zelluna's top competitors are
Lytix Biopharma,
Nykode Therapeutics,
Bergenbio Asa,
Oncoinvent Asa,
Glycostem Therapeutics,
Pan Cancer T,
T-Knife Therapeutics,
Circio Holding Asa,
Onk Therapeutics,
Ultimovacs Asa.
Zelluna's support email address is post@zelluna.com
Zelluna's categories are Biotechnology Research
Zelluna's founding year is 2016
